Following bioinformatic filtering for clinically relevant genes obtained using breast cancer gene expression data sets, we obtained a panel of 21 factors that we referred to as the HMGA1 reduced signature (HRS), whose expression was linked to poor prognosis in cancer. This evidence concerns the gene HMGA1 and cancer.